Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 1,656 shares at $12.00 ($20K) on 2019-09-19, disclosed to the SEC on 2019-09-19.
Scheduled sale ($20k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MGTA | SELL | 2019-11-01 | $53K | — | Filing → |
| MGTA | SELL | 2019-10-03 | $50K | — | Filing → |
| MGTA | SELL | 2019-09-16 | $10K | — | Filing → |